| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Medicine |
From the Heart & Stroke Richard Lewar Centre of Excellence in Cardiovascular Research and the Faculty of Medicine (J.C., A.C., A.P., M.H.); Departments of Medicine, Physiology, and Laboratory Medicine and Pathobiology (J.C., R.G., M.H.); Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy (N.T.); and McLaughlin Centre for Molecular Medicine (M.H.), University of Toronto, Ontario; and Division of Cell and Molecular Biology (M.H.), Toronto General Hospital Research Institute, Ontario, Canada.
Correspondence to Mansoor Husain, MD, Toronto General Hospital, 200 Elizabeth St, EN12-221, Toronto, Ontario, Canada M5G 2C4. E-mail mansoor.husain{at}utoronto.ca
Calcium transients are known to control several transition points in the eukaryotic cell cycle. For example, we have previously shown that a coordinate elevation in the intracellular free calcium ion concentration is required for G1- to S-phase cell cycle progression in vascular smooth muscle cells (VSMC). However, the molecular basis for this Ca2+ sensitivity was not known. Using buffers with differing [Ca2+], we found that the kinase activity of mouse and human cyclin E/CDK2, but not other G1/S-associated cell cycle complexes, was responsive to physiological changes in [Ca2+]. We next determined that this Ca2+-responsive kinase activity was dependent on a direct interaction between calmodulin (CaM), one of the major Ca2+-signal transducers of eukaryotic cells, and cyclin E. Pharmacological inhibition of CaM abrogated the Ca2+ sensitivity of cyclin E/CDK2 and retarded mouse VSMC proliferation by causing G1 arrest. We next defined the presence of a highly conserved 22 amino acid N-terminal CaM-binding motif in mammalian cyclin E genes (dissociation constant, 1.5±0.1 µmol/L) and showed its essential role in mediating Ca2+-sensitive kinase activity of cyclin E/CDK2. Mutant human cyclin E protein, lacking this CaM-binding motif, was incapable of binding CaM or responding to [Ca2+]. Taken together, these findings reveal CaM-dependent cyclin E/CDK2 activity as a mediator of the known Ca2+ sensitivity of the G1/S transition of VSMC.
Key Words: calcium calmodulin cell cycle cell cycle progression CDK2 cyclin E vascular smooth muscle cells
Related Article:
Circ. Res. 2006 98: 1240-1243.
This article has been cited by other articles:
![]() |
W. Liang, J. B. Ray, J. Z. He, P. H. Backx, and M. E. Ward Regulation of Proliferation and Membrane Potential by Chloride Currents in Rat Pulmonary Artery Smooth Muscle Cells Hypertension, August 1, 2009; 54(2): 286 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Jahnke, O. Sabido, and D. Freyssenet Control of mitochondrial biogenesis, ROS level, and cytosolic Ca2+ concentration during the cell cycle and the onset of differentiation in L6E9 myoblasts Am J Physiol Cell Physiol, May 1, 2009; 296(5): C1185 - C1194. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Afroze, A. M. Sadi, M. A. Momen, S. Gu, S. Heximer, and M. Husain c-Myb-Dependent Inositol 1,4,5-Trisphosphate Receptor Type-1 Expression in Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1305 - 1311. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Koledova and R. A. Khalil Ca2+, Calmodulin, and Cyclins in Vascular Smooth Muscle Cell Cycle Circ. Res., May 26, 2006; 98(10): 1240 - 1243. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |